Scottish adolescents get Stelara

[Fred]

The Scottish Medicines Consortium (SMC) has completed its assessment of Stelara and advises NHS Boards and Area Drug and Therapeutic Committees (ADTCs) on its use in NHS Scotland in adolescent patients.

The advice is summarised as follows:

Quote:

---

Following an abbreviated submission ustekinumab (Stelara) is accepted for restricted use within NHS Scotland.

Indication under review: Treatment of moderate to severe plaque psoriasis in adolescent
patients from the age of 12 years and older, who are inadequately controlled by, or are intolerant
to, other systemic therapies or phototherapies.

SMC restriction: continued treatment should be restricted to patients who achieve at least 75%
improvement in their Psoriasis Area and Severity Index (PASI 75) within 16 weeks.

Source: scottishmedicines.org.uk

[jiml]

The Scottish Medicines Consortium (SMC) has completed its assessment of Stelara and advises NHS Boards and Area Drug and Therapeutic Committees (ADTCs) on its use in NHS Scotland.

The advice is summarised as follows:

Quote:

---

Following an abbreviated submission ustekinumab (Stelara) is accepted for restricted use within NHS Scotland.

Indication under review: Treatment of moderate to severe plaque psoriasis in adolescent
patients from the age of 12 years and older, who are inadequately controlled by, or are intolerant
to, other systemic therapies or phototherapies.

SMC restriction: continued treatment should be restricted to patients who achieve at least 75%
improvement in their Psoriasis Area and Severity Index (PASI 75) within 16 weeks.

Source: scottishmedicines.org.uk

More good news for juveniles and their parents having this now available in Scotland it certainly proves the safety of the drug
Let's hope the rest of the U.K. Will follow suit soon and give some respite to desperate teenagers here

[Quest4Cure]

hey, about time!

[Caroline]

Indeed, this seems like the records of Stelara, which is on the market for quite some time, are getting better and better.
Historical patients records from the real practice are always good in proving a medication is good. Only the longer term of use will prove this.